Cargando…
Cardiac manifestations of PRKAG2 mutation
BACKGROUND: The Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) cardiac syndrome is characterized by glycogen accumulation in the cardiac tissue. The disease presents clinically with hypertrophic cardiomyopathy (HCM), and it is often associated with conduction abnormalities. CASE...
Autores principales: | Banankhah, Pooya, Fishbein, Gregory A., Dota, Anthony, Ardehali, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751825/ https://www.ncbi.nlm.nih.gov/pubmed/29298659 http://dx.doi.org/10.1186/s12881-017-0512-6 |
Ejemplares similares
-
PRKAG2 mutation: An easily missed cardiac specific non-lysosomal glycogenosis
por: Aggarwal, Varun, et al.
Publicado: (2015) -
A Case Series on Cardiac and Skeletal Involvement in Two Families with PRKAG2 Mutations
por: Sri, Anita, et al.
Publicado: (2019) -
Cardiomiopatia PRKAG2
por: Sternick, Eduardo Back
Publicado: (2022) -
Patient with a PRKAG2 mutation who developed Immunoglobulin A nephropathy: a case report
por: Giudici, Michael C, et al.
Publicado: (2019) -
Abnormal expression of PRKAG2-AS results in dysfunction of cardiomyocytes through regulating PRKAG2 transcription by interacting with PPARG
por: Song, Xiao-Wei, et al.
Publicado: (2023)